COVID-19 Traditional Medicine Treatment Market

Traditional Chinese medicine has been playing a critical role in the prevention, treatment and rehabilitation of the COVID-19.Official figures showed that, up to Sunday, 91.6 percent of the patients in Hubei province, the epicenter of the outbreak, and 92.4 percent of the patients nationwide have been treated with TCM."Three formulas and three medicines" have been proven to be effective in curbing the virus, according to the State Administration of Traditional Chinese Medicine.

COVID-19 Traditional Medicine Treatment Market contains market size and forecasts of COVID-19 Traditional Chinese Medicine Treatment in global, including the following market information:

Global COVID-19 Traditional Chinese Medicine Treatment Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global COVID-19 Traditional Chinese Medicine Treatment Market Sales, 2017-2022, 2023-2028, (K Units)

Global top five COVID-19 Traditional Chinese Medicine Treatment companies in 2021 (%)

The global COVID-19 Traditional Chinese Medicine Treatment market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Lianhua Qingwen Capsule Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of COVID-19 Traditional Chinese Medicine Treatment include Shijiazhuang Yiling Pharmaceutical, Tianjin Chase Sun Pharmaceutical, Beijing Juxiechang Pharmaceutical and Beijing Yiling Pharmaceutical, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

We surveyed the COVID-19 Traditional Chinese Medicine Treatment manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global COVID-19 Traditional Chinese Medicine Treatment Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global COVID-19 Traditional Chinese Medicine Treatment Market Segment Percentages, by Type, 2021 (%)

• Lianhua Qingwen Capsule
• Xuebijing Injection
• Jinhua Qinggan Granule

Global COVID-19 Traditional Chinese Medicine Treatment Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global COVID-19 Traditional Chinese Medicine Treatment Market Segment Percentages, by Application, 2021 (%)

• Hospital
• Special Clinic
• Recovery Center

Global COVID-19 Traditional Chinese Medicine Treatment Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global COVID-19 Traditional Chinese Medicine Treatment Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

• Key companies COVID-19 Traditional Chinese Medicine Treatment revenues in global market, 2017-2022 (Estimated), ($ millions)
• Key companies COVID-19 Traditional Chinese Medicine Treatment revenues share in global market, 2021 (%)
• Key companies COVID-19 Traditional Chinese Medicine Treatment sales in global market, 2017-2022 (Estimated), (K Units)
• Key companies COVID-19 Traditional Chinese Medicine Treatment sales share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Shijiazhuang Yiling Pharmaceutical
• Tianjin Chase Sun Pharmaceutical
• Beijing Juxiechang Pharmaceutical
• Beijing Yiling Pharmaceutical